Potential new targets involved in 1,3-dinitrobenzene induced testicular toxicity

Sophie Ludwig1, Helen Tinwell, David Rouquié

  • 1Bayer SAS, Department of Research Toxicology, 355 rue Dostoïevski, 06903 Sophia-Antipolis, France.

Toxicology Letters
|July 31, 2012
PubMed

Insights

1,3-Dinitrobenzene (DNB) causes testicular damage by inducing germ cell apoptosis and altering cell cycle progression. This chemical also impacts steroid hormone biosynthesis, suggesting potential endocrine disruption alongside direct testicular toxicity.

Area of Science:

  • Toxicology
  • Reproductive Biology
  • Molecular Biology

Background:

  • 1,3-Dinitrobenzene (DNB) is known to induce testicular injury and germ cell apoptosis in rodents.
  • The precise mechanisms underlying DNB-induced testicular toxicity remain poorly understood.

Purpose of the Study:

  • To elucidate the pathogenesis of testicular effects induced by 1,3-Dinitrobenzene (DNB).
  • To investigate the impact of DNB on testicular cell cycle, apoptosis, and steroidogenesis.

Main Methods:

  • Standard toxicological assessments and molecular tools were employed.
  • Global transcriptomics analysis was performed on rat testes following DNB exposure.
  • In vitro H295R steroidogenesis assay was utilized to confirm steroid hormone effects.

Main Results:

  • Multiple oral doses of DNB (≥4mg/kg/day) caused significant testicular lesions in rats.
  • Transcriptomics revealed alterations in cell cycle progression (e.g., polo-like kinase genes) and cell death pathways.
  • Single DNB dose did not cause adverse changes, but multiple doses affected plasma testosterone and testicular steroidogenesis gene expression, confirmed in vitro.

Conclusions:

  • 1,3-Dinitrobenzene (DNB) induces testicular apoptosis and interferes with the cell cycle.
  • DNB exposure modulates steroid hormone biosynthesis, indicating potential endocrine system interference.
  • The contribution of endocrine changes to DNB-induced testicular lesions requires further investigation.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
Electrophilic Aromatic Substitution: Nitration of Benzene01:20

Electrophilic Aromatic Substitution: Nitration of Benzene

The nitration of benzene is an example of an electrophilic aromatic substitution reaction. It involves the formation of a very powerful electrophile, the nitronium ion, which is linear in shape. The reaction occurs through the interaction of two strong acids, sulfuric and nitric acid.
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...